My Medtronic 522 insulin pump weighs 100 grams, which is equivalent to 20 nickels. That’s not much, just a pocket full of change, but lately…
A new study conducted by the Institute for Alternative Futures (IAF) identified California, Texas, Florida, New York, Ohio, Illinois, Georgia, Pennsylvania, North Carolina and Michigan as “diabetes hot spots,” where the burden of diabetes will be greatest in the next 15 years...
Kellogg refers to sugar as the “misunderstood nutrient.” According to the Web site, “Sugar does not cause obesity, type 2 diabetes, heart disease or hyperactivity.”
The number of diabetics in Japan is estimated at over eight million, with millions more suffering from impaired glucose tolerance, or prediabetes. The Japan Diabetes Society says that after last week's devastating earthquake and tsunami in north-east Japan, there are 400-500 survivors with type 1 diabetes in the stricken area...
Pluristem Therapeutics, Inc., an Israeli based company developing placenta-based cell therapies, and New York University (NYU) Medical Center today announced the formation of a partnership to study the use of Pluristem’s proprietary placenta-derived PLX cells for the treatment of diabetic foot ulcers...
The Chinese State Food and Drug Administration (SFDA) has approved Victoza for the treatment of type 2 diabetes.
Diabetes is a rapidly growing disease in China, and Victoza offers a unique treatment option by effectively reducing HbA1c and weight with a low risk of hypoglycemia in people with type 2 diabetes inadequately controlled by oral anti-diabetic agents...
Approximately 150 children and teenagers throughout the U.S., and several from around the world have been selected to travel to Washington, D.C. this summer to represent their state and country and remind Congress and the Administration of the critical need to find better treatments...
I ran 22.5 miles on Friday morning.
I haven’t felt very well for the last few days and my blood sugar levels have been a little out of whack (actually,…
For three days we calculated the carbs in Ashley’s food. We figured the insulin needed. We learned how to put new lancets in the insulin pen...
Biodel Inc. has selected two new formulations of recombinant human insulin for clinical testing and is accelerating clinical development plans of these mealtime insulin drug candidates.
The new formulations, BIOD-105 and BIOD-107, are designed to result in more rapid insulin action compared to currently marketed...